Scholarlink

<p>This study compares the retro-auricular robotic-assisted approach using two or three robotic instruments with conventional open neck dissection in patients with early N stage oral cavity cancer. Twenty-six patients with T1-3N0-1M0 disease underwent supraomohyoid neck dissection between 2018 and 2023 (13 robotic, 13 open). Perioperative outcomes, including hospital stay, drainage duration, complications, and lymph node yield, showed no significant differences (median lymph nodes: 20 vs. 21; <i>p</i> = 0.950). During a median follow-up of 743&#xa0;days, no recurrences or deaths occurred. In the last five robotic cases, a third instrument (ProGrasp Forceps) was added without increasing operative time (<i>p</i> = 0.803). Robotic-assisted neck dissection via the retro-auricular route is a safe and effective alternative for early stage oral cavity cancer patients, particularly those with clinical N0 disease, preserving oncologic outcomes while improving cosmetic appearance.</p>

错误：搜索内容不能为空，请输入英文关键词
错误：关键词超出字数限制，请精简
高级检索

Comparable outcomes with improved esthetics: da Vinci-assisted neck dissection for early stage oral cancers

  • 期刊论文

  • 出版模式：

    开放获取

  • 发表日期：

    2025年8月17日

查看全文
  • Wen-Chun Lin,
  • Man-Wei Hua,
  • Chen-Chi Wang

摘要

This study compares the retro-auricular robotic-assisted approach using two or three robotic instruments with conventional open neck dissection in patients with early N stage oral cavity cancer. Twenty-six patients with T1-3N0-1M0 disease underwent supraomohyoid neck dissection between 2018 and 2023 (13 robotic, 13 open). Perioperative outcomes, including hospital stay, drainage duration, complications, and lymph node yield, showed no significant differences (median lymph nodes: 20 vs. 21; p = 0.950). During a median follow-up of 743 days, no recurrences or deaths occurred. In the last five robotic cases, a third instrument (ProGrasp Forceps) was added without increasing operative time (p = 0.803). Robotic-assisted neck dissection via the retro-auricular route is a safe and effective alternative for early stage oral cavity cancer patients, particularly those with clinical N0 disease, preserving oncologic outcomes while improving cosmetic appearance.